NEW YORK, July 25 – GeneMachines has sold two OmniGrid microarrayers to the Genome Institute of Singapore, the company said Wednesday. 

The Genome Institute will use the microarrayers in its work on zebrafish and mouse model systems, as well as cancer genomics and other research that comprises part of Singapore’s promised $4 billion investment in genomics and biotechnology. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.